Collegium Pharmaceutical Inc
COLL
$22.97+0.86%
Delayed · as of Sep 21, 2026, 3:31 PM ET
Mkt cap
$1.12B
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$199.88M
EPS (H1 2026)
$-0.02
Gross Margin (qtr ended 2026-06-30)
55.18%
Profit Margin (qtr ended 2026-06-30)
-7.53%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported COLL revenue for 2026-06-30 was $199.9M. Net income was -$15.1M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. COLL currently screens at market cap $1.12B.
Use this COLL research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full COLL income, balance, and cash tables.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Collegium Pharmaceutical Inc (COLL) revenue for Jun 30, 2026 was $199.9M. Net income was -$15.1M. Statements: https://lician.com/financials/coll
Collegium Pharmaceutical Inc (COLL) market capitalization is $1.12B on the latest cached snapshot.
Collegium Pharmaceutical Inc (COLL) cached previous close $22.77; day range $22.51 – $23.23; volume 580,540. Session quote: https://lician.com/quote/coll
Collegium Pharmaceutical Inc (COLL) latest cached earnings event is "COLL earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached COLL filing is 8-K · Aug 13, 2026. Filings: https://lician.com/sec/coll